Pharmacokinetics in Early Drug Research
Altern Lab Anim
.
1997 Jan-Feb;25(1):17-31.
Authors
D E Leahy
1
,
R Duncan
2
,
H J Ahr
3
,
M K Bayliss
4
,
A B de Boer
5
,
F Darvas
6
,
J H Fentem
7
,
J R Fry
8
,
R Hopkins
9
,
J B Houston
10
,
J Karlsson
11
,
G L Kedderis
12
,
M K Pratten
13
,
P Prieto
7
,
D A Smith
14
,
D W Straughan
15
Affiliations
1
Lead Discovery Department, ZENECA Pharmaceuticals, Alderley Park, Macclesfield, UK.
2
Centre for Polymer Therapeutics, The School of Pharmacy, University of London, London, UK.
3
PH-PD-T Research Toxicology, Bayer AG, Wuppertal, Germany.
4
Bioanalysis and Drug Metabolism, Glaxo Wellcome, Ware, UK.
5
Division of Pharmacology, LACDR, Sylvius Laboratories, Leiden University, Leiden, The Netherlands.
6
ComGenex Ltd, Budapest, Hungary.
7
ECVAM, JRC Environment Institute, Ispra, Italy.
8
Department of Physiology and Pharmacology, University of Nottingham Medical School, Nottingham, UK.
9
Corning Hazleton, Harrogate, UK.
10
Department of Pharmacy, University of Manchester, Manchester, UK.
11
Elan Corporation Research Institute, Trinity College, Dublin, Ireland.
12
CIIT, Research Triangle Park, USA.
13
Department of Human Anatomy and Cell Biology, University of Nottingham Medical School, Nottingham, UK.
14
Department of Drug Metabolism, Pfizer Central Research, Sandwich, UK.
15
FRAME, Nottingham, UK.
PMID:
26554347
No abstract available